AUA Capital Management’s Allergan plc AGN Stock Holding History

AUA Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-40	Closed	-$10K	–	218
2017 Q1	$10K	Hold	40	–	–	0.01%	166
2016 Q4	$8K	Buy	+40	New	+$8.29K	0.01%	183

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AUA Capital Management's AGN Position: Q2 2017 in Review

AUA Capital Management sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 40 shares — an estimated $10K sold.

AUA Capital Management first reported a position in AGN in Q4 2016 and held it in 2 quarters. The position peaked at $10K in Q1 2017. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

AUA Capital Management reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
AUA Capital Management sold 40 Allergan plc shares in Q2 2017, an estimated $10K.
AUA Capital Management first reported a position in Allergan plc in Q4 2016 and held it in 2 quarters.
AUA Capital Management's Allergan plc position peaked at $10K in Q1 2017.
1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on AUA Capital Management's 13F filing for Q2 2017, filed 26 Jul 2017.